MNMD.Q Archives • ShroomStocks.ca

Category

MNMD.Q

Category

MNMD.Q

Mind Medicine Inc. (MNMD.Q) Puts Your Mind at Ease

Post date
January 25, 2022
Posted by
Kieran Robertson
Posted in best psychedelic companies, best psychedelic stocks, best psychedelic treatment, clinical trials psychedelics, companies doing psychedelics research, GAD, Generalized Anxiety Disorder, investing in psychedelics, LSD, LSD research, Major depressive disorder, MDD, medical psychedelics, Mind Medicine, Mind Medicine Inc., MindMEd, MNMD.Q, psychedelic assisted therapy, psychedelic market, Psychedelics, psychedelics stocks, therapy for major depression disorder
Comments
0

MindMed (MNMD.Q) partners with Forian, bringing data analysis to their psychedelic clinical trials

Post date
August 24, 2021
Posted by
Piers Eaton
Posted in Biotech, Data Factory, Forian, Health Science, LSD, Mind Medicine, MindMEd, MNMD.Q, Mushrooms, Psychedelics
Comments
0

MindMed (MNMD.Q) partners with Forian, bringing data analysis to their psychedelic clinical trials

Post date
August 24, 2021
Posted by
Piers Eaton
Posted in Biotech, Data Factory, Forian, Health Science, LSD, Mind Medicine, MindMEd, MNMD.Q, Mushrooms, Psychedelics
Comments
0

MindMed (MNMD.Q) partners with Forian, bringing data analysis to their psychedelic clinical trials

Post date
August 24, 2021
Posted by
Piers Eaton
Posted in Biotech, Data Factory, Forian, Health Science, LSD, Mind Medicine, MindMEd, MNMD.Q, Mushrooms, Psychedelics
Comments
0

MindMed (MNMD.Q) expand efficacy of clinical trials by adding data consolidator, Datavant

Post date
July 8, 2021
Posted by
Joseph
Posted in Datavant, healthcare, MindMEd, MNMD.Q, Psychedelics
Comments
0

Nothing more to load.